Maravai Lifesciences Holdings Inc (MRVI) financials · rev $185.7M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Maravai Lifesciences Holdings Inc (MRVI) rev $185.7M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $185.7M | $259.2M |
| Cost of Revenue | $151.8M | $150.9M |
| Gross Profit | $34.0M | $108.3M |
| Operating Income | -$215.3M | -$235.6M |
| Net Income | -$130.8M | -$144.8M |
| EPS (Diluted) | -$0.90 | -$1.05 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $770.6M | $1.01B |
| Current Assets | $296.3M | $429.1M |
| Cash & Equivalents | $216.9M | $322.4M |
| Inventory | $40.5M | $50.1M |
| PP&E | $151.5M | $164.5M |
| Total Liabilities | $397.9M | $431.0M |
| Current Liabilities | $44.9M | $57.0M |
| Short-term Debt | $5.44M | $5.44M |
| Long-term Debt | $286.3M | $290.5M |
| Total Debt | $291.8M† | $295.9M† |
| Shareholders' Equity | $212.4M | $325.3M |
| Retained Earnings | $10.1M | $140.9M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$57.6M | $7.46M |
| CapEx | $13.1M | $29.7M |
| Investing Cash Flow | -$31.4M | -$24.3M |
| Financing Cash Flow | -$16.5M | -$235.7M |
| Net Change in Cash | -$105.5M | -$252.6M |
| Free Cash Flow | -$70.7M | -$22.2M |
FAQ
What is MRVI P/E and revenue?
Maravai Lifesciences Holdings Inc (MRVI) rev $185.7M.
What is MRVI revenue?
Maravai Lifesciences Holdings Inc last cached revenue is $185.7M (FY2025).
Is MRVI profitable?
Maravai Lifesciences Holdings Inc last cached net income is -$130.8M (FY2025).
What are MRVI total assets?
Maravai Lifesciences Holdings Inc last cached total assets are $770.6M (FY2025).
What is MRVI free cash flow?
Maravai Lifesciences Holdings Inc last cached free cash flow is -$70.7M (FY2025).
Not investment advice. Cached statements, not a live tape.